ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur: R.T. Saygitov
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: "Paediatrician" Publishers LLC 2008-08-01
Cyfres:Вопросы современной педиатрии
Mynediad Ar-lein:https://vsp.spr-journal.ru/jour/article/view/1441

Eitemau Tebyg